SPY767.50+0.13%QQQ719.02+0.09%BTC/USD—DIA519.52+0.12%GLD378.71−0.26%TLT79.52+0.08%
Benzinga
Updated: Oct 19, 2026

Chris Schott's Stock Ratings

JP Morgan Analyst

Chris Schott is an analyst at JP Morgan. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends.

Overall Average Return

8.93%

Smart Score

68.4%

Overall Average Return Percentile

57th

Number of Ratings

100
Buy NowGet Alert
10/16/2026IDXXBuy Now
IDEXX Laboratories
$555.2435.08%$775 → $750MaintainsOverweightGet Alert
10/12/2026TEVABuy Now
Teva Pharmaceutical Indus
$41.1221.6%$40 → $50MaintainsOverweightGet Alert
10/12/2026BIIBBuy Now
Biogen
$236.0027.12%$210 → $300UpgradeNeutral → OverweightGet Alert
10/09/2026PFEBuy Now
Pfizer
$29.431.94%$28 → $30MaintainsNeutralGet Alert
10/08/2026ABBVBuy Now
AbbVie
$282.606.16%$285 → $300MaintainsOverweightGet Alert
10/07/2026GILDBuy Now
Gilead Sciences
$153.3310.87%$160 → $170MaintainsOverweightGet Alert
10/06/2026REGNBuy Now
Regeneron Pharmaceuticals
$782.0021.48%$900 → $950MaintainsOverweightGet Alert
10/05/2026MRKBuy Now
Merck & Co
$143.8514.7%$150 → $165MaintainsOverweightGet Alert
09/29/2026JNJBuy Now
Johnson & Johnson
$253.7912.3%$270 → $285MaintainsNeutralGet Alert
09/28/2026LLYBuy Now
Eli Lilly
$1.24K20.76%$1400 → $1500MaintainsOverweightGet Alert
08/26/2026AMRXBuy Now
Amneal Pharmaceuticals
$19.3613.64% → $22Reinstates → OverweightGet Alert
08/07/2026ZTSBuy Now
Zoetis
$79.0145.55%$130 → $115MaintainsOverweightGet Alert
08/07/2026RPRXBuy Now
Royalty Pharma
$60.272.87%$58 → $62MaintainsOverweightGet Alert
07/31/2026BMYBuy Now
Bristol-Myers Squibb
$58.8124.12%$67 → $73MaintainsOverweightGet Alert
07/13/2026MRKBuy Now
Merck & Co
$143.85-2.68%$135 → $140MaintainsOverweightGet Alert
07/09/2026ABBVBuy Now
AbbVie
$282.60-0.92%$260 → $280MaintainsOverweightGet Alert
07/08/2026PFEBuy Now
Pfizer
$29.43-4.86%$30 → $28MaintainsNeutralGet Alert
07/07/2026LLYBuy Now
Eli Lilly
$1.24K12.71%$1300 → $1400MaintainsOverweightGet Alert
05/18/2026REGNBuy Now
Regeneron Pharmaceuticals
$782.008.7%$950 → $850MaintainsOverweightGet Alert
05/08/2026ZTSBuy Now
Zoetis
$79.0164.54%$190 → $130MaintainsOverweightGet Alert
05/08/2026VTRSBuy Now
Viatris
$18.39-2.12%$17 → $18MaintainsNeutralGet Alert
05/07/2026RPRXBuy Now
Royalty Pharma
$60.27-3.77%$50 → $58MaintainsOverweightGet Alert
05/07/2026ELANBuy Now
Elanco Animal Health
$23.4927.71%$28 → $30MaintainsOverweightGet Alert
04/30/2026TEVABuy Now
Teva Pharmaceutical Indus
$41.12-2.72%$35 → $40MaintainsOverweightGet Alert
04/06/2026MRKBuy Now
Merck & Co
$143.85-6.15%$125 → $135MaintainsOverweightGet Alert
03/05/2026JNJBuy Now
Johnson & Johnson
$253.79-1.49%$225 → $250MaintainsNeutralGet Alert
02/19/2026ELANBuy Now
Elanco Animal Health
$23.4919.2%$24 → $28MaintainsOverweightGet Alert
02/05/2026LLYBuy Now
Eli Lilly and Co
$1.24K4.66%$1150 → $1300MaintainsOverweightGet Alert
02/02/2026REGNBuy Now
Regeneron Pharmaceuticals
$782.0021.48%$850 → $950MaintainsOverweightGet Alert
12/16/2025TEVABuy Now
Teva Pharmaceutical Indus
$41.12-14.88%$28 → $35MaintainsOverweightGet Alert
12/15/2025PRGOBuy Now
Perrigo
$16.0312.29%$20 → $18MaintainsNeutralGet Alert
11/18/2025LLYBuy Now
Eli Lilly
$1.24K-7.42%$1050 → $1150MaintainsOverweightGet Alert
11/11/2025OGNBuy Now
Organon
$13.75-12.73%$14 → $12MaintainsUnderweightGet Alert
11/06/2025TEVABuy Now
Teva Pharmaceutical Indus
$41.12-31.91%$26 → $28MaintainsOverweightGet Alert
11/06/2025PRGOBuy Now
Perrigo
$16.0324.77%$32 → $20DowngradeOverweight → NeutralGet Alert
11/05/2025ZTSBuy Now
Zoetis
$79.01153.13%$230 → $200MaintainsOverweightGet Alert
11/04/2025IDXXBuy Now
IDEXX Laboratories
$555.2439.58%$675 → $775MaintainsOverweightGet Alert
11/03/2025ABBVBuy Now
AbbVie
$282.60-8%$250 → $260MaintainsOverweightGet Alert
10/31/2025GILDBuy Now
Gilead Sciences
$153.33-2.17%$145 → $150MaintainsOverweightGet Alert
10/07/2025ELANBuy Now
Elanco Animal Health
$23.492.17%$18 → $24UpgradeNeutral → OverweightGet Alert
10/03/2025TEVABuy Now
Teva Pharmaceutical Indus
$41.12-36.77%$23 → $26MaintainsOverweightGet Alert
09/16/2025GILDBuy Now
Gilead Sciences
$153.33-5.43%$135 → $145MaintainsOverweightGet Alert
09/16/2025LLYBuy Now
Eli Lilly
$1.24K-15.47%$1100 → $1050MaintainsOverweightGet Alert
09/16/2025AMRXBuy Now
Amneal Pharmaceuticals
$19.36-27.69%$12 → $14MaintainsOverweightGet Alert
09/16/2025ABBVBuy Now
AbbVie
$282.60-16.84%$200 → $235MaintainsOverweightGet Alert
08/08/2025LLYBuy Now
Eli Lilly
$1.24K-11.44%$1100 → $1100ReiteratesOverweight → OverweightGet Alert
08/07/2025PRGOBuy Now
Perrigo
$16.03118.34%$38 → $35MaintainsOverweightGet Alert
08/04/2025IDXXBuy Now
IDEXX Laboratories
$555.2421.57%$550 → $675MaintainsOverweightGet Alert
06/09/2025REGNBuy Now
Regeneron Pharmaceuticals
$782.002.3%$950 → $800MaintainsOverweightGet Alert
05/12/2025TEVABuy Now
Teva Pharmaceutical Indus
$41.12-44.07%$21 → $23UpgradeNeutral → OverweightGet Alert
05/05/2025BIIBBuy Now
Biogen
$236.00-25.85%$185 → $175MaintainsNeutralGet Alert
04/30/2025REGNBuy Now
Regeneron Pharmaceuticals
$782.0021.48%$1000 → $950MaintainsOverweightGet Alert
03/31/2025REGNBuy Now
Regeneron Pharmaceuticals
$782.0027.88%$1100 → $1000MaintainsOverweightGet Alert
03/27/2025GILDBuy Now
Gilead Sciences
$153.33-15.22%$120 → $130MaintainsOverweightGet Alert
02/24/2025AMRXBuy Now
Amneal Pharmaceuticals
$19.36-38.02%$9 → $12UpgradeNeutral → OverweightGet Alert
02/12/2025GILDBuy Now
Gilead Sciences
$153.33-21.74%$115 → $120MaintainsOverweightGet Alert
01/29/2025GILDBuy Now
Gilead Sciences
$153.33-25%$105 → $115MaintainsOverweightGet Alert
01/27/2025TEVABuy Now
Teva Pharmaceutical Indus
$41.12-48.93%$18 → $21MaintainsNeutralGet Alert
11/13/2024ABBVBuy Now
AbbVie
$282.60-29.23%$210 → $200MaintainsOverweightGet Alert
11/07/2024GILDBuy Now
Gilead Sciences
$153.33-31.52%$100 → $105MaintainsOverweightGet Alert
11/04/2024BIIBBuy Now
Biogen
$236.00-11.02%$220 → $210MaintainsNeutralGet Alert
10/24/2024REGNBuy Now
Regeneron Pharmaceuticals
$782.0047.06%$1200 → $1150MaintainsOverweightGet Alert
10/21/2024TEVABuy Now
Teva Pharmaceutical Indus
$41.12-56.23%$16 → $18MaintainsNeutralGet Alert
10/11/2024IDXXBuy Now
IDEXX Laboratories
$555.243.56%$630 → $575MaintainsOverweightGet Alert
10/11/2024ZTSBuy Now
Zoetis
$79.01191.1%$225 → $230MaintainsOverweightGet Alert
10/09/2024GILDBuy Now
Gilead Sciences
$153.33-34.78%$95 → $100MaintainsOverweightGet Alert
09/13/2024LLYBuy Now
Eli Lilly
$1.24K-11.44%$1050 → $1100MaintainsOverweightGet Alert
09/06/2024OGNBuy Now
Organon
$13.7545.45%$18 → $20DowngradeNeutral → UnderweightGet Alert
09/06/2024AMRXBuy Now
Amneal Pharmaceuticals
$19.36-53.51% → $9UpgradeUnderweight → NeutralGet Alert
08/02/2024REGNBuy Now
Regeneron Pharmaceuticals
$782.0053.45%$1150 → $1200MaintainsOverweightGet Alert
07/25/2024ABBVBuy Now
AbbVie
$282.60-25.69%$190 → $210MaintainsOverweightGet Alert
07/11/2024LLYBuy Now
Eli Lilly and Co
$1.24K-19.49%$900 → $1000MaintainsOverweightGet Alert
06/17/2024REGNBuy Now
Regeneron Pharmaceuticals
$782.0047.06%$1050 → $1150MaintainsOverweightGet Alert
05/01/2024LLYBuy Now
Eli Lilly and Co
$1.24K-27.54%$850 → $900MaintainsOverweightGet Alert
04/11/2024BIIBBuy Now
Biogen
$236.001.69%$270 → $240MaintainsNeutralGet Alert
03/15/2024LLYBuy Now
Eli Lilly and Co
$1.24K-31.57%$775 → $850MaintainsOverweightGet Alert
03/08/2024TEVABuy Now
Teva Pharmaceutical Indus
$41.12-65.95% → $14UpgradeUnderweight → NeutralGet Alert
02/28/2024PRGOBuy Now
Perrigo
$16.03155.77%$48 → $41MaintainsOverweightGet Alert
02/20/2024RPRXBuy Now
Royalty Pharma
$60.27-30.31%$45 → $42MaintainsOverweightGet Alert
02/06/2024IDXXBuy Now
IDEXX Laboratories
$555.2413.46%$600 → $630MaintainsOverweightGet Alert
11/08/2023LLYBuy Now
Eli Lilly
$1.24K——Reiterates → OverweightGet Alert
11/02/2023IDXXBuy Now
IDEXX Laboratories
$555.24-0.94%$600 → $550MaintainsOverweightGet Alert
10/20/2023AMGNBuy Now
Amgen
$424.94-36.46% → $270ReinstatesNeutral → NeutralGet Alert
10/16/2023PFEBuy Now
Pfizer
$29.4315.53%$36 → $34MaintainsNeutralGet Alert
10/06/2023PFEBuy Now
Pfizer
$29.4322.32%$39 → $36MaintainsNeutralGet Alert
08/09/2023PRGOBuy Now
Perrigo
$16.03199.44%$45 → $48MaintainsOverweightGet Alert
08/09/2023LLYBuy Now
Eli Lilly
$1.24K-51.7%$510 → $600MaintainsOverweightGet Alert
08/02/2023IDXXBuy Now
IDEXX Laboratories
$555.248.06%$550 → $600MaintainsOverweightGet Alert
07/28/2023LLYBuy Now
Eli Lilly
$1.24K-58.94%$475 → $510MaintainsOverweightGet Alert
05/04/2023LLYBuy Now
Eli Lilly
$1.24K-61.76%$430 → $475MaintainsOverweightGet Alert
04/28/2023LLYBuy Now
Eli Lilly
$1.24K-65.38%$400 → $430MaintainsOverweightGet Alert
03/31/2023REGNBuy Now
Regeneron Pharmaceuticals
$782.0021.48%$900 → $950MaintainsOverweightGet Alert
02/23/2023MRKBuy Now
Merck & Co
$143.85-13.1%$120 → $125MaintainsOverweightGet Alert
02/07/2023IDXXBuy Now
IDEXX Laboratories
$555.24-0.94%$525 → $550MaintainsOverweightGet Alert
01/20/2023REGNBuy Now
Regeneron Pharmaceuticals
$782.008.7% → $850UpgradeNeutral → OverweightGet Alert
11/15/2022VTRSBuy Now
Viatris
$18.39-23.87%$13 → $14MaintainsNeutralGet Alert
11/14/2022CHRSBuy Now
Coherus BioSciences
$0.971034.02%$13 → $11MaintainsNeutralGet Alert
11/14/2022EQRXBuy Now
EQRx
———DowngradeNeutral → UnderweightGet Alert
11/14/2022TEVABuy Now
Teva Pharmaceutical Indus
$41.12-75.68%$11 → $10DowngradeNeutral → UnderweightGet Alert
10/18/2022RPRXBuy Now
Royalty Pharma
$60.27-13.72%$50 → $52MaintainsOverweightGet Alert

Recent Analyst Stock Rating News

Pfizer, Thermo Fisher Scientific And More: CNBC’s ‘Final Trades’
Pfizer, Thermo Fisher Scientific And More: CNBC’s ‘Final Trades’
CNBC Final Trades: Weiss picked 10-year Treasuries, Thomas chose XAR, Firestone favored TMO, and Terranova selected PFE.
Transcript: Johnson & Johnson Q3 2026 Earnings Conference Call
Transcript: Johnson & Johnson Q3 2026 Earnings Conference Call
Johnson & Johnson (NYSE:JNJ) held its third-quarter earnings conference call on Tuesday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For real-time access to
Transcript: Eli Lilly Q2 2026 Earnings Conference Call
Transcript: Eli Lilly Q2 2026 Earnings Conference Call
Eli Lilly (NYSE:LLY) held its second-quarter earnings conference call on Wednesday. Below is the complete transcript from the call. Benzinga APIs provide real-time access to earnings call transcripts and financial data.
Zoetis Reports Q2 2026 Results: Full Earnings Call Transcript
Zoetis Reports Q2 2026 Results: Full Earnings Call Transcript
On Thursday, Zoetis (NYSE:ZTS) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you by Benzinga APIs. For real-time access to our
Full Transcript: Pfizer Q2 2026 Earnings Call
Full Transcript: Pfizer Q2 2026 Earnings Call
Pfizer (NYSE:PFE) released second-quarter financial results and hosted an earnings call on Tuesday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcripts and financial
IDEXX Laboratories Q2 2026 Earnings Call Transcript
IDEXX Laboratories Q2 2026 Earnings Call Transcript
IDEXX Laboratories (NASDAQ:IDXX) reported second-quarter financial results on Tuesday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to you by
Royalty Pharma Reports Q1 2026 Results: Full Earnings Call Transcript
Royalty Pharma Reports Q1 2026 Results: Full Earnings Call Transcript
Transcript: IDEXX Laboratories Q1 2026 Earnings Conference Call
Transcript: IDEXX Laboratories Q1 2026 Earnings Conference Call
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved